Dec 3 (Reuters) - The U.S. Food and Drug Administration has approved Axogen's nerve repair graft, the health regulator said on Wednesday.
(Reporting by Sriparna Roy, Padmanabhan Ananthan and Puyaan Singh in Bengaluru; Editing by Sherry Jacob-Phillips)